Spectral Med Inc's stock is facing challenges as it slips in today’s trading session.
Spectral Med Inc (EDT.TO) is down 2.84% today, closing at CA$1.37. This decline raises concerns for investors who are closely watching the company’s performance amid its ongoing developments.
Advertisement
Spectral Med Inc
EDT.TO
EDT.TO
Spectral Med Inc
WealthAwesomeAdvertisement
Market cap
$413.72M
52W high
$1.76
52W low
$1.05
1W change
+0.71%
Beta
0.21
Analyst Price Targets
Based on analyst covering EDT
Wall Street analysts forecast EDT stock price to rise 123.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.15
+123.4% Upside
Current Price
C$1.41
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EDT's historical volatility
30-Day Vol
25.7%
Annualized
90-Day Vol
26.8%
Annualized
Trend (90d)
+12.1%
Annualized drift
90d Mean
C$1.47
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.43 | C$1.31 – C$1.56 |
| 60 trading days | C$1.45 | C$1.28 – C$1.64 |
| 90 trading days | C$1.47 | C$1.26 – C$1.72 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should be cautious as Spectral Med Inc's recent stock performance reflects potential underlying issues, despite its advancements in regulatory processes.
Stock Drops 2.84% Today
Spectral Med Inc's market cap now stands at CA$413.7 million, reflecting investor concerns as the stock slides.
Bull case
The company has made significant progress in its clinical trials and is moving toward FDA approval for its PMX treatment, which could lead to future growth.
Bear case
The current drop in stock price may signal investor skepticism about the company's ability to deliver on its promises, especially given recent financial results and market conditions.
Advertisement
Current Stock Performance
As of the latest trading session, Spectral Med Inc's stock is down 2.84%, closing at CA$1.37. This decline is notable as the company has been in the spotlight for its recent FDA filing and clinical trial results, yet investors are reacting cautiously.
Market Reaction and Investor Sentiment
The market's response to Spectral Med Inc’s stock slide today suggests uncertainty among investors. Despite positive developments in their clinical trials, the drop may indicate doubt about the company's ability to capitalize on these advancements. Investors should keep a close eye on upcoming announcements and financial results to gauge future performance.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
